ingest
cdrApp
2018-06-13T18:53:10.159Z
51cd2fe2-3fd7-401f-a923-a97bc3db68a2
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-06-13T20:06:08.056Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2018-06-13T20:06:19.558Z
Adding technical metadata derived by FITS
addDatastream
MD_FULL_TEXT
fedoraAdmin
2018-06-13T20:06:42.699Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2018-06-13T20:07:05.143Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-11T14:24:56.113Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-18T10:05:44.511Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-21T18:53:15.172Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-27T19:27:32.617Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-12T10:13:00.240Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-17T15:31:02.650Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-21T20:25:10.403Z
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Soha
Bazyar
Creator
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Biomedical engineering
Combined Radiotherapy Immunotherapy; Microbeam Radiation Therapy; Minibeam Radiation Therapy; Radiation Therapy; radiotherapy Immune Response; Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
2018
2018-05
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
Soha
Bazyar
Author
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
Spring 2018
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy, Microbeam Radiation Therapy, Minibeam Radiation Therapy, Radiation Therapy, radiotherapy Immune Response, Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
Biomedical Engineering
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Soha
Bazyar
Creator
UNC/NCSU Joint Department of Biomedical Engineering
School of Medicine
DESKTOP GENERATED MICROPLANAR X-RAY BEAMS AND THEIR BIOLOGICAL EFFECTS
Cancer affects 1 in 2 men and 1 in 3 women in the US and about half of all cancer patients receive some type of radiation therapy sometime during the course of their treatment. Normal tissue toxicity is the most important dose-limiting side effect of radiotherapy. This effect not only occurs after conventional broad beam radiotherapy (BB) but also following new radiation modalities namely, intensity modulated radiotherapy and proton therapy.
Microbeam radiotherapy (MRT) is a novel preclinical approach for radiotherapy, which delivers spatially fractionated submillimeter lines of the collimated quasi-parallel of a single high-dose (100Gy<) radiation (peaks), separated by wider nonirradiated regions (valleys). Interestingly, the preclinical studies on animal models have consistently demonstrated the selective tumoricidal effect of MRT with the ability to even cure the aggressive orthotropic tumor models while sparing the normal tissue.
Most of the MRT studies have been conducted in spars synchrotron facilities around the world. To make this technology more available for preclinical biomedical studies and facilitate the translation of this promising modality to the clinic, here a desktop approach for applying MRT has been sought. My dissertation goal was to develop a more accessible microbeam approach, study its effectiveness and evaluate some of the hypothetical underlying radiobiological mechanism of the desktop MRT approach.
In this work, first, the effect of MRT and BB on normal mouse brain will be evaluated using batteries of neurocognitive tests, up to 8-months post irradiation. Next, a novel method for applying microbeams using an industrial cabinet animal irradiator will be introduced and a detailed description of its final characteristics will be given, including a comprehensive evaluation of the treatment geometry and a full-scale phantom-based quantification of its dosimetric output. Subsequently, the in-vitro and in-vivo efficacy of this new approach will be investigated. Later, the role of the acquired immune system will be evaluated in the tumor response after MRT. Finally, future project directions will be described briefly. Based on the results of this work, the author’s belief that our approach for applying MRT can be easily reproduced in other research facilities for radiobiological research and has definite clinical translation potential.
2018-05
2018
Biomedical engineering
Combined Radiotherapy Immunotherapy; Microbeam Radiation Therapy; Minibeam Radiation Therapy; Radiation Therapy; radiotherapy Immune Response; Spatial Fractionated Radiotherapy
eng
Doctor of Philosophy
Dissertation
Yueh
Lee
Thesis advisor
Otto
Zhou
Thesis advisor
Joel
Tepper
Thesis advisor
Maureen
Su
Thesis advisor
David
Lalush
Thesis advisor
text
University of North Carolina at Chapel Hill
Degree granting institution
Bazyar_unc_0153D_17644.pdf
uuid:3d215c0c-d88c-4688-9939-b0d262fced54
2020-06-13T00:00:00
2018-04-21T14:00:18Z
proquest
application/pdf
23352866